Valneva SE (VALN) Cash from Financing Activities (2021 - 2024)

Valneva SE's (VALN) quarterly Cash from Financing Activities came in at -$4.9 million in Q4 2024, down 112.34% year-on-year from $39.7 million in Q1 2024, and down 100.03% quarter-over-quarter from $18.3 billion in Q3 2024.

Valneva SE (VALN) Cash from Financing Activities (2021 - 2024) Analysis & Trends

Valneva SE has disclosed Cash from Financing Activities across 4 years of filings, most recently posting -$4.9 million for Q4 2024.

  • Cash from Financing Activities for Q4 2024 came in at -$4.9 million, down 112.34% year-over-year; the trailing twelve-month figure through Dec 2024 was $387.6 million (up 495.47% YoY), and the FY2025 annual result was -$722871.0, down 102.2% from the prior year.
  • Cash from Financing Activities came in at -$4.9 million for Q4 2024 at Valneva SE, down from $18.3 billion in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $18.3 billion in Q3 2024 to a low of -$17.9 billion in Q2 2024.
  • The 4-year median for Cash from Financing Activities is $8.9 million (2022), against an average of $53.6 million.
  • Peak annual rise in Cash from Financing Activities reached 61612.28% in 2023, while the deepest fall reached 9392.38% in 2023.
  • Valneva SE's Cash from Financing Activities stood at $91.4 million in 2021, then increased by 4.39% to $95.4 million in 2022, then sank by 58.32% to $39.7 million in 2023, then sank by 112.34% to -$4.9 million in 2024.
  • The last three Cash from Financing Activities figures came in at -$4.9 million (Q4 2024), $18.3 billion (Q3 2024), and -$17.9 billion (Q2 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - -
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 7.00 Mn
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -600,000.00
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 53,000.00
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn -538.80 Mn
9 Abivax 94.26 Bn 94.26 Bn - 85,464.43
10 Valneva SE 167.33 Mn 44.10 Mn 5.08 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.90 Mn
Dec 31, 2024 -4.90 Mn
Sep 30, 2024 18.26 Bn
Sep 30, 2024 18.26 Bn
Jun 30, 2024 -17.86 Bn
Jun 30, 2024 -17.86 Bn
Mar 31, 2024 -8.10 Mn
Mar 31, 2024 -8.10 Mn
Dec 31, 2023 39.75 Mn
Dec 31, 2023 39.75 Mn
Sep 30, 2023 10.34 Bn
Sep 30, 2023 10.34 Bn
Jun 30, 2023 -10.31 Bn
Jun 30, 2023 -10.31 Bn
Mar 31, 2023 -4.10 Mn
Mar 31, 2023 -4.10 Mn
Dec 31, 2022 95.38 Mn
Dec 31, 2022 95.38 Mn
Sep 30, 2022 16.76 Mn
Sep 30, 2022 16.76 Mn